Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) Debt to Equity (2019 - 2025)

Viemed Healthcare (VMD) has disclosed Debt to Equity for 6 consecutive years, with $0.09 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity rose 187.47% year-over-year to $0.09, compared with a TTM value of $0.09 through Dec 2025, up 187.47%, and an annual FY2025 reading of $0.09, up 187.47% over the prior year.
  • Debt to Equity was $0.09 for Q4 2025 at Viemed Healthcare, down from $0.16 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.16 in Q3 2025 and bottomed at $0.03 in Q1 2025.
  • Average Debt to Equity over 5 years is $0.07, with a median of $0.06 recorded in 2021.
  • The sharpest move saw Debt to Equity crashed 61.43% in 2024, then soared 349.6% in 2025.
  • Year by year, Debt to Equity stood at $0.06 in 2021, then dropped by 24.6% to $0.05 in 2022, then skyrocketed by 34.98% to $0.06 in 2023, then plummeted by 51.01% to $0.03 in 2024, then surged by 187.47% to $0.09 in 2025.
  • Business Quant data shows Debt to Equity for VMD at $0.09 in Q4 2025, $0.16 in Q3 2025, and $0.03 in Q2 2025.